Influenza Vaccine Market Registering a CAGR of 7.20% from 2021 to 2030

According to a new report published by Allied Market Research, titled, "Influenza Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2021-2030" The global influenza vaccine market size was valued at $5024.60 million in 2020, and is projected to reach $10,127.0 million by 2030, registering a CAGR of 7.20% from 2021 to 2030. The viral infection which occurs due to flu in the respiratory system is called influenza. Influenza virus travels through respiratory droplets and it is contagious. It can also spread from one person to another while talking or due to physical contact. The influenza virus circulates continuously, causing regional epidemics and outbreaks which leads to thousands of deaths.

Changing character of the virus is compelling an annual change in the vaccine strain to match the influenza virus strain. Healthcare organizations all over the world like Centers for Disease Control and Prevention (CDC) have suggested vaccines like baloxavir marboxil (Xofluza) for the treatment of influenza have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐨𝐮𝐜𝐡𝐞𝐫: https://www.alliedmarketresearch.com/request-sample/1437

Increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines is one of the crucial factors driving the market growth. Moreover, increase in investment by leading market players across the globe and rise in government funding have facilitated the launch of therapeutically effective vaccines drive the influenza vaccine market growth.

The immunization camps and programs conducted by various healthcare organizations have been affected due to the coronavirus pandemic. Having said that, the rates of the vaccination for flu has reached its peak in the pandemic due to a push by various healthcare operatives and government who are providing free vaccination to the citizens. Awareness has also raised amongst the populations due to the fear of flu and COVID-19.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/1437

The influenza vaccine market is segmented into vaccine type, technology, age group, route of administration and region. By vaccine type, it is divided into quadrivalent and trivalent. By technology, it is classified into egg-based and cell-based. By age group, it is divided into pediatric and adult. By route of administration, it is categorized into injection and nasal spray. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Some of the key players operating in the influenza vaccine market are AstraZeneca plc., Biodiem, CSL Limited, Emergent BioSolutions, F. Hoffmann-La Roche Ltd., Gamma Vaccines Pty Ltd., GlaxoSmithKline plc, Merck & Co. Inc. (Merck Sharp & Dohme Corp.), Novartis AG, Pfizer, Inc., Sanofi Pasteur SA, and Sinovac Biotech Ltd.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global influenza vaccine market to identify the prevailing opportunities.
• This study presents the competitive landscape of the global influenza vaccine market to predict the competitive environment across geographies.
• Comprehensive analysis of factors that drive and restrict the influenza vaccine market growth is provided.
• Region- & country-wise analysis is provided to understand the influenza vaccine market trends and dynamics.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: https://www.alliedmarketresearch.com/request-for-customization/1437

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Surgical Robotic System Market: https://www.alliedmarketresearch.com/surgical-robotic-systems-market-A06827

Healthcare Interoperability Solutions Market: https://www.alliedmarketresearch.com/healthcare-interoperability-solutions-market-A07075

Surgical Drains Market: https://www.alliedmarketresearch.com/wound-drainage-surgical-drains-market-A07517

Contact Us:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

This release was published on openPR.